1227266-47-8

Basic information

• Product Name: 4-(6-amino-pyridazin-3-yl)-phenol
• Synonyms: 4-(6-amino-pyridazin-3-yl)-phenol
• CAS NO: 1227266-47-8
• Molecular Weight: 187.201
• Mol File: 1227266-47-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(6-amino-pyridazin-3-yl)-phenol(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(6-amino-pyridazin-3-yl)-phenol(1227266-47-8)
• EPA Substance Registry System: 4-(6-amino-pyridazin-3-yl)-phenol(1227266-47-8)

Safety Data

• Hazardous Substances Data: 1227266-47-8(Hazardous Substances Data)

Upstream product

• 5469-69-2 6-chloro-pyridazin-3-ylamine 
• 71597-85-8 (p-hydroxyphenyl)boronic acid 

Downstream Products

• 1318791-93-3 4-{6-imino-3-[4-benzyloxyphenyl]-6H-pyridazin-1-yl}-butyric acid hydrobromide 
• 1318791-94-4 4-{6-imino-3-[4-(3-methoxy-benzyloxy)-phenyl]-6H-pyridazin-1-yl}-butyric acid hydrobromide 
• 1318791-95-5 4-{6-imino-3-[4-(3-nitro-benzyloxy)-phenyl]-6H-pyridazin-1-yl}-butyric acid hydrobromide 
• 1318791-96-6 4-[6-imino-3-(4-prop-2-ynyloxy-phenyl)-6H-pyridazin-1-yl]-butyric acid hydrobromide 
• 1318791-89-7 allyl-4-{6-imino-3-[4-benzyloxyphenyl]-6H-pyridazin-1-yl}-butyric acid hydrobromide 
• 1318791-90-0 allyl-4-{6-imino-3-[4-(3-methoxy-benzyloxy)-phenyl]-6H-pyridazin-1-yl}-butyric acid hydrobromide 
• 1318791-91-1 allyl-4-{6-imino-3-[4-(3-nitro-benzyloxy)-phenyl]-6H-pyridazin-1-yl}-butyric acid hydrobromide 
• 1318791-92-2 allyl-4-[6-Imino-3-(4-prop-2-ynyloxy-phenyl)-6H-pyridazin-1-yl]-butyric acid hydrobromide 
• 1318791-85-3 6-(4-benzyloxyphenyl)-pyridazin-3-yl amine 
• 1318791-88-6 6-(4-prop-2-ynyloxy-phenyl)-pyridazin-3-ylamine 
• 1318791-86-4 6-[4-(3-methoxy-benzyloxy)-phenyl]-pyridazin-3-yl amine 
• 1318791-87-5 6-[4-(3-nitro-benzyloxy)-phenyl]-pyridazin-3-yl amine 

Relevant articles and documents

Synthesis and evaluation of highly potent GABAA receptor antagonists based on gabazine (SR-95531)

A selection of highly potent analogues based on the gabazine structure is described. Their syntheses are carried out in just four steps, and their potencies for antagonism at the GABAA receptor were measured. All antagonists showed significantly higher potencies compared to the parent competitive antagonist, gabazine.